COLUMBUS, Ohio - Installed Building Products, Inc. (NYSE:IBP), a national installer of insulation and complementary building products, announced Monday the acquisition of Echols Glass & Mirror, Inc.
Interferon regulatory factor-4 binding protein (IBP) is a novel upstream activator of Rho GTPases. Our previous studies have shown that ectopic expression of IBP was correlated with malignant ...
Installed Building Products has shown top-line and bottom-line growth for the last 8 years. The company added over $100 MM from 10 acquisitions in 2022 and has similar plans for coming years. I would ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback